Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Loda

Showing results (141-150 of 409) with videos related to

Pageof 41
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|September 12, 2020
Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate CancerDeborah L Burkhart, Katherine L Morel, Kristine M Wadosky, et al.
Nature Genetics|December 22, 2005
Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumorChiaki Takahashi, Bernardo Contreras, Tsuyoshi Iwanaga, et al.
The Journal of Urology|August 18, 2004
Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesisCeren G Korkmaz, Kemal S Korkmaz, Judith Manola, et al.
Glycobiology|October 3, 2024
Compromised CDK12 activity causes dependency on the high activity of O-GlcNAc transferaseSatu Pallasaho, Aishwarya Gondane, Julia Kutz, et al.
Molecular Cancer Research : MCR|December 13, 2022
The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate CancerChaoran Ma, Yinglu Zhou, Giuseppe Nicolò Fanelli, et al.
Carcinogenesis|April 12, 2015
Tumor expression of adiponectin receptor 2 and lethal prostate cancerJennifer R Rider, Michelangelo Fiorentino, Rachel Kelly, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2016
Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular SubtypesKathryn L Penney, Andreas Pettersson, Irene M Shui, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2010
Preclinical model of organotypic culture for pharmacodynamic profiling of human tumorsValentina Vaira, Giuseppe Fedele, Saumyadipta Pyne, et al.
Cancer Research|September 5, 2006
The isopeptidase USP2a protects human prostate cancer from apoptosisCarmen Priolo, Dan Tang, Mohan Brahamandan, et al.
Elife|September 11, 2020
A single-cell atlas of the mouse and human prostate reveals heterogeneity and conservation of epithelial progenitorsLaura Crowley, Francesco Cambuli, Luis Aparicio, et al.
Pageof 41

Showing results (141-150 of 409) with videos related to

Sort By:
Pageof 41
Cancer Prevention Research (Philadelphia, Pa.)|September 12, 2020
Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate CancerDeborah L Burkhart, Katherine L Morel, Kristine M Wadosky, et al.
Nature Genetics|December 22, 2005
Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumorChiaki Takahashi, Bernardo Contreras, Tsuyoshi Iwanaga, et al.
The Journal of Urology|August 18, 2004
Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesisCeren G Korkmaz, Kemal S Korkmaz, Judith Manola, et al.
Glycobiology|October 3, 2024
Compromised CDK12 activity causes dependency on the high activity of O-GlcNAc transferaseSatu Pallasaho, Aishwarya Gondane, Julia Kutz, et al.
Molecular Cancer Research : MCR|December 13, 2022
The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate CancerChaoran Ma, Yinglu Zhou, Giuseppe Nicolò Fanelli, et al.
Carcinogenesis|April 12, 2015
Tumor expression of adiponectin receptor 2 and lethal prostate cancerJennifer R Rider, Michelangelo Fiorentino, Rachel Kelly, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2016
Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular SubtypesKathryn L Penney, Andreas Pettersson, Irene M Shui, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2010
Preclinical model of organotypic culture for pharmacodynamic profiling of human tumorsValentina Vaira, Giuseppe Fedele, Saumyadipta Pyne, et al.
Cancer Research|September 5, 2006
The isopeptidase USP2a protects human prostate cancer from apoptosisCarmen Priolo, Dan Tang, Mohan Brahamandan, et al.
Elife|September 11, 2020
A single-cell atlas of the mouse and human prostate reveals heterogeneity and conservation of epithelial progenitorsLaura Crowley, Francesco Cambuli, Luis Aparicio, et al.
Pageof 41